Cwm LLC grew its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) by 550.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,105 shares of the company’s stock after buying an additional 6,859 shares during the period. Cwm LLC’s holdings in Inspire Medical Systems were worth $1,711,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. SouthState Corp acquired a new stake in shares of Inspire Medical Systems in the second quarter valued at approximately $27,000. GAMMA Investing LLC grew its position in Inspire Medical Systems by 559.3% during the third quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after buying an additional 151 shares in the last quarter. Quarry LP increased its stake in Inspire Medical Systems by 105.4% during the 2nd quarter. Quarry LP now owns 343 shares of the company’s stock worth $46,000 after acquiring an additional 176 shares during the period. Daiwa Securities Group Inc. acquired a new position in Inspire Medical Systems in the 2nd quarter valued at $53,000. Finally, Van ECK Associates Corp lifted its position in shares of Inspire Medical Systems by 7.5% during the 2nd quarter. Van ECK Associates Corp now owns 1,029 shares of the company’s stock valued at $138,000 after acquiring an additional 72 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.
Inspire Medical Systems Stock Down 5.5 %
NYSE INSP opened at $198.91 on Wednesday. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40. The business’s fifty day moving average is $199.38 and its 200 day moving average is $182.86. The company has a market cap of $5.91 billion, a price-to-earnings ratio of -361.65 and a beta of 1.34.
Insider Buying and Selling at Inspire Medical Systems
In related news, insider Randy Ban sold 4,861 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $188.55, for a total value of $916,541.55. Following the completion of the sale, the insider now directly owns 3,056 shares in the company, valued at $576,208.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, Director Shawn Mccormick sold 800 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total transaction of $176,000.00. Following the completion of the sale, the director now owns 23,140 shares in the company, valued at $5,090,800. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Randy Ban sold 4,861 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $188.55, for a total value of $916,541.55. Following the completion of the transaction, the insider now owns 3,056 shares in the company, valued at approximately $576,208.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,692 shares of company stock worth $1,099,207. 4.10% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on INSP. Truist Financial restated a “buy” rating and issued a $240.00 price target (up previously from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Royal Bank of Canada reissued an “outperform” rating and issued a $260.00 target price on shares of Inspire Medical Systems in a report on Wednesday, August 7th. Robert W. Baird cut their price target on shares of Inspire Medical Systems from $220.00 to $200.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. KeyCorp reduced their price target on shares of Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Finally, Leerink Partners boosted their price objective on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the company a “market perform” rating in a research report on Tuesday, September 10th. Five equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $216.62.
View Our Latest Stock Analysis on INSP
Inspire Medical Systems Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Further Reading
- Five stocks we like better than Inspire Medical Systems
- 3 Tickers Leading a Meme Stock Revival
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What is a support level?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP – Free Report).
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.